Xenofon Papanikolaou

Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)

Madhav V. Dhodapkar, Rachael Sexton, Sarah Waheed et al. · Blood · 2013 · 197 citations

Medicine, Oncology, Radiology +10

Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design

Dimitrios A. Koutoukidis, Joanne Land, Allan Hackshaw et al. · British Journal of Cancer · 2020 · 71 citations · Full text

Education, Rehabilitation Medicine, Health-related Fitness +14

Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis

Xenofon Papanikolaou, Tarun K. Garg, Erming Tian et al. · Oncotarget · 2014 · 43 citations · Full text

Medicine, Cell Biology, Pharmacology +17

Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma

Bo Hu, Yu Chen, Saad Z. Usmani et al. · PLoS ONE · 2013 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse

Xenofon Papanikolaou, Panagiotis Repousis, Dimitris Maltezas et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 33 citations

Medicine, Hematology, Internal Medicine +17